Cargando…

Parotid gland-recovery after radiotherapy in the head and neck region - 36 months follow-up of a prospective clinical study

BACKGROUND: The aim of the present study was to evaluate the recovery potential of the parotid glands after using either 3D-conformal-radiotherapy (3D-CRT) or intensity-modulated radiotherapy (IMRT) by sparing one single parotid gland. METHODS: Between 06/2002 and 10/2008, 117 patients with head and...

Descripción completa

Detalles Bibliográficos
Autores principales: Hey, Jeremias, Setz, Juergen, Gerlach, Reinhard, Janich, Martin, Hildebrandt, Guido, Vordermark, Dirk, Gernhardt, Christian R, Kuhnt, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201902/
https://www.ncbi.nlm.nih.gov/pubmed/21951317
http://dx.doi.org/10.1186/1748-717X-6-125
_version_ 1782214938077429760
author Hey, Jeremias
Setz, Juergen
Gerlach, Reinhard
Janich, Martin
Hildebrandt, Guido
Vordermark, Dirk
Gernhardt, Christian R
Kuhnt, Thomas
author_facet Hey, Jeremias
Setz, Juergen
Gerlach, Reinhard
Janich, Martin
Hildebrandt, Guido
Vordermark, Dirk
Gernhardt, Christian R
Kuhnt, Thomas
author_sort Hey, Jeremias
collection PubMed
description BACKGROUND: The aim of the present study was to evaluate the recovery potential of the parotid glands after using either 3D-conformal-radiotherapy (3D-CRT) or intensity-modulated radiotherapy (IMRT) by sparing one single parotid gland. METHODS: Between 06/2002 and 10/2008, 117 patients with head and neck cancer were included in this prospective, non-randomised clinical study. All patients were treated with curative intent. Salivary gland function was assessed by measuring stimulated salivary flow at the beginning, during and at the end of radiotherapy as well as 1, 6, 12, 24, and 36 months after treatment. Measurements were converted to flow rates and normalized relative to rates before treatment. Mean doses (D(mean)) were calculated from dose-volume histograms based on computed tomographies of the parotid glands. RESULTS: Patients were grouped according to the D(mean )of the spared parotid gland having the lowest radiation exposure: Group I - D(mean )< 26 Gy (n = 36), group II - D(mean )26-40 Gy (n = 45), and group III - D(mean )> 40 Gy (n = 36). 15/117 (13%) patients received IMRT. By using IMRT as compared to 3D-CRT the D(mean )of the spared parotid gland could be significantly reduced (D(mean )IMRT vs. 3D-CRT: 21.7 vs. 34.4 Gy, p < 0.001). The relative salivary flow rates (RFSR) as a function of the mean parotid dose after 24 and 36 months was in group I 66% and 74%, in group II 56% and 49%, and in group III 31% and 24%, respectively. Multiple linear regression analyses revealed that the parotid gland dose and the tumor site were the independent determinants 12 and 36 months after the end of RT. Patients of group I and II parotid gland function did recover at 12, 24, and 36 months after the end of RT. CONCLUSIONS: If a D(mean )< 26 Gy for at least one parotid gland can be achieved then this is sufficient to reach complete recovery of pre-RT salivary flow rates. The radiation volume which depends on tumor site did significantly impact on the D(mean )of the parotids, and thus on the saliva flow and recovery of parotid gland.
format Online
Article
Text
id pubmed-3201902
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32019022011-10-26 Parotid gland-recovery after radiotherapy in the head and neck region - 36 months follow-up of a prospective clinical study Hey, Jeremias Setz, Juergen Gerlach, Reinhard Janich, Martin Hildebrandt, Guido Vordermark, Dirk Gernhardt, Christian R Kuhnt, Thomas Radiat Oncol Research BACKGROUND: The aim of the present study was to evaluate the recovery potential of the parotid glands after using either 3D-conformal-radiotherapy (3D-CRT) or intensity-modulated radiotherapy (IMRT) by sparing one single parotid gland. METHODS: Between 06/2002 and 10/2008, 117 patients with head and neck cancer were included in this prospective, non-randomised clinical study. All patients were treated with curative intent. Salivary gland function was assessed by measuring stimulated salivary flow at the beginning, during and at the end of radiotherapy as well as 1, 6, 12, 24, and 36 months after treatment. Measurements were converted to flow rates and normalized relative to rates before treatment. Mean doses (D(mean)) were calculated from dose-volume histograms based on computed tomographies of the parotid glands. RESULTS: Patients were grouped according to the D(mean )of the spared parotid gland having the lowest radiation exposure: Group I - D(mean )< 26 Gy (n = 36), group II - D(mean )26-40 Gy (n = 45), and group III - D(mean )> 40 Gy (n = 36). 15/117 (13%) patients received IMRT. By using IMRT as compared to 3D-CRT the D(mean )of the spared parotid gland could be significantly reduced (D(mean )IMRT vs. 3D-CRT: 21.7 vs. 34.4 Gy, p < 0.001). The relative salivary flow rates (RFSR) as a function of the mean parotid dose after 24 and 36 months was in group I 66% and 74%, in group II 56% and 49%, and in group III 31% and 24%, respectively. Multiple linear regression analyses revealed that the parotid gland dose and the tumor site were the independent determinants 12 and 36 months after the end of RT. Patients of group I and II parotid gland function did recover at 12, 24, and 36 months after the end of RT. CONCLUSIONS: If a D(mean )< 26 Gy for at least one parotid gland can be achieved then this is sufficient to reach complete recovery of pre-RT salivary flow rates. The radiation volume which depends on tumor site did significantly impact on the D(mean )of the parotids, and thus on the saliva flow and recovery of parotid gland. BioMed Central 2011-09-27 /pmc/articles/PMC3201902/ /pubmed/21951317 http://dx.doi.org/10.1186/1748-717X-6-125 Text en Copyright ©2011 Hey et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Hey, Jeremias
Setz, Juergen
Gerlach, Reinhard
Janich, Martin
Hildebrandt, Guido
Vordermark, Dirk
Gernhardt, Christian R
Kuhnt, Thomas
Parotid gland-recovery after radiotherapy in the head and neck region - 36 months follow-up of a prospective clinical study
title Parotid gland-recovery after radiotherapy in the head and neck region - 36 months follow-up of a prospective clinical study
title_full Parotid gland-recovery after radiotherapy in the head and neck region - 36 months follow-up of a prospective clinical study
title_fullStr Parotid gland-recovery after radiotherapy in the head and neck region - 36 months follow-up of a prospective clinical study
title_full_unstemmed Parotid gland-recovery after radiotherapy in the head and neck region - 36 months follow-up of a prospective clinical study
title_short Parotid gland-recovery after radiotherapy in the head and neck region - 36 months follow-up of a prospective clinical study
title_sort parotid gland-recovery after radiotherapy in the head and neck region - 36 months follow-up of a prospective clinical study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201902/
https://www.ncbi.nlm.nih.gov/pubmed/21951317
http://dx.doi.org/10.1186/1748-717X-6-125
work_keys_str_mv AT heyjeremias parotidglandrecoveryafterradiotherapyintheheadandneckregion36monthsfollowupofaprospectiveclinicalstudy
AT setzjuergen parotidglandrecoveryafterradiotherapyintheheadandneckregion36monthsfollowupofaprospectiveclinicalstudy
AT gerlachreinhard parotidglandrecoveryafterradiotherapyintheheadandneckregion36monthsfollowupofaprospectiveclinicalstudy
AT janichmartin parotidglandrecoveryafterradiotherapyintheheadandneckregion36monthsfollowupofaprospectiveclinicalstudy
AT hildebrandtguido parotidglandrecoveryafterradiotherapyintheheadandneckregion36monthsfollowupofaprospectiveclinicalstudy
AT vordermarkdirk parotidglandrecoveryafterradiotherapyintheheadandneckregion36monthsfollowupofaprospectiveclinicalstudy
AT gernhardtchristianr parotidglandrecoveryafterradiotherapyintheheadandneckregion36monthsfollowupofaprospectiveclinicalstudy
AT kuhntthomas parotidglandrecoveryafterradiotherapyintheheadandneckregion36monthsfollowupofaprospectiveclinicalstudy